Iv Watch announced it raised $10.7 Million in an initial filing from an offering of $14.5 Million

Company

Location

About

ivWatch is a Newport News, Virginia-based medical technology company founded in 2010 that has developed the first FDA-cleared and CE-marked device to continuously monitor peripheral IVs using visible and near-infrared light with predictive algorithms, performing over 18,000 checks per hour to detect infiltration and extravasation in real time. Holding nearly 70 patents and backed by over 35 clinical studies, ivWatch has earned global recognition, including Fast Company’s Most Innovative Companies, Inc.’s Best in Business, and a Top 3 finish at the 2024 Startup World Cup Grand Finale.